A longitudinal assessment of frailty in young adult survivors of childhood cancer
A longitudinal assessment of frailty in young adult survivors of childhood cancer
批准号:
9056542
负责人:
Kirsten Kimberlie Ness
金额:
$53.52万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-07 至 2019-04-30
关键词:
AdolescentAgeAgingAlkylating AgentsAnthracyclinesBehaviorBleomycinBrain NeoplasmsCancer SurvivorCell LineCephalicCharacteristicsChestChildChildhoodChildhood Acute Lymphocytic LeukemiaChildhood Cancer TreatmentChronicChronic DiseaseClinicalComorbidityDataDemographic FactorsDevelopmentDiagnosisDietDietary PracticesDisease MarkerDoseEarly treatmentElderlyEvaluationExerciseFatigueFemaleFundingGenderGeneral PopulationHabitsHealthHealth behaviorHodgkin DiseaseHospitalizationHousingIndividualInstitutionInterventionLifeLong-Term SurvivorsMalignant Childhood NeoplasmMalignant NeoplasmsMeasurementMeasuresModalityNormal tissue morphologyNutritionalOnset of illnessOrganOutcomeParticipantPersonsPhenotypePhysical FitnessPhysical FunctionPhysical activityPhysiologicalPopulationPremature aging syndromePrevalenceRadiationRecruitment ActivityReportingResearchResearch PersonnelResourcesRiskRisk FactorsSaint Jude Children&aposs Research HospitalScheduleSeveritiesShortness of BreathSmokingSmoking StatusSurvivorsSymptomsTestingTimeToxic effectTravelTreatment FactorTreatment-Related CancerUnited StatesVisitcancer cellchildhood cancer survivorcohortdesigndisabilityfitnessfrailtyfunctional lossinnovationinterestmembermortalitypeerpre-clinicalprematurepreventpublic health relevancescreeningsextherapy designyoung adult
中文摘要
描述(由申请人提供):在过去的四十年中,儿童癌症的治疗取得了进展,因此,今天,超过80%的被诊断为恶性肿瘤的儿童将成为长期幸存者。目前,在美国有超过35万的儿童癌症幸存者;这些人中有近25万人年龄在40岁以下。不幸的是,儿童癌症的治疗仍然需要破坏恶性细胞系的药物,而正常组织并不总是幸免。虽然早期治疗相关的器官特异性毒性并不总是很明显,但许多儿童癌症幸存者报告的症状会干扰日常生活,包括运动引起的呼吸短促、疲劳和参加体育活动的能力下降。这些症状可能是早衰或身体虚弱的标志。虚弱是最常见于老年人的一种表型;它指的是那些非常容易受到不利健康结果影响的人。虚弱可能有助于解释为什么近三分之二的儿童癌症幸存者在确诊后30年内至少患有一种严重的慢性健康状况,为什么儿童癌症幸存者比同龄人更有可能因非产科原因住院,以及为什么他们的死亡率比年龄和性别匹配的一般人群高8倍以上。本提案的目的是列举一组儿童期癌症的年轻成年幸存者中随时间推移的生理虚弱的患病率,描述虚弱与慢性疾病的发展或进展之间的联系,并描述这一人群中个人因素、癌症相关治疗方式、健康行为和虚弱之间的联系。
英文摘要
DESCRIPTION (provided by applicant): Treatment for children with cancer has progressed over the past four decades so that, today, over 80% of children diagnosed with a malignancy will become long-term survivors. Currently, there are over 350,000 survivors of childhood cancer living in the United States; nearly 250,000 of these individuals are younger than age 40 years. Unfortunately, treatment for childhood cancer continues to require agents designed to destroy malignant cell lines, and normal tissue is not always spared. While early treatment-related organ specific toxicities are not always apparent, many childhood cancer survivors report symptoms that interfere with daily life, including exercise induced shortness of breath, fatigue, and reduce capacity to participate in physical activity. These symptoms may be a hallmark of premature aging, or frailty. Frailty is a phenotype most commonly described in older adults; it indicates persons who are highly vulnerable to adverse health outcomes. Frailty may help explain why nearly two thirds of childhood cancer survivors have at least one severe chronic health condition 30 years from diagnosis, why childhood cancer survivors are more likely than peers to be hospitalized for non-obstetrical reasons, and why they have mortality rates more than eight times higher than age-and-gender matched members of the general population. The aims of this proposal are to enumerate the prevalence of physiologic frailty over time in a group of young adult survivors of childhood cancer, to describe the association between frailty and the development or progression of chronic conditions, and to describe the associations between personal factors, cancer-related treatment modalities, health behaviors, and frailty in this population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Web-based Physical Activity Intervention for Children with ALL
-
批准号:9298607
-
项目类别:
-
资助金额:$86.99万
-
财政年份:2016
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
A longitudinal assessment of frailty in young adult survivors of childhood cancer
-
批准号:8630497
-
项目类别:
-
资助金额:$64.85万
-
财政年份:2014
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
A longitudinal assessment of frailty in young adult survivors of childhood cancer
-
批准号:8846554
-
项目类别:
-
资助金额:$53.52万
-
财政年份:2014
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors
-
批准号:8037771
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2010
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors
-
批准号:7788569
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2010
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
-
批准号:7795129
-
项目类别:
-
资助金额:$66.41万
-
财政年份:2009
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
-
批准号:7656171
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2009
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
-
批准号:8220778
-
项目类别:
-
资助金额:$60.53万
-
财政年份:2009
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
-
批准号:8054848
-
项目类别:
-
资助金额:$63.57万
-
财政年份:2009
-
负责人:Kirsten Kimberlie Ness
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: